IgG from atopic dermatitis patients induces IL-17 and IL-10 production in infant intrathymic TCD4 and TCD8 cells

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
INTERNATIONAL JOURNAL OF DERMATOLOGY, v.57, n.4, p.434-440, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
IntroductionOur group recently demonstrated that IgG modulates T cell cytokine production during the maturation process in the human thymus. The effects of this modulation are IgG repertoire dependent and can exert a systemic and long-term impact. ObjectiveTo investigate whether IgG from atopic dermatitis (AD) patients can modulate cytokine production of infant intrathymic TCD4 and TCD8 cells in vitro. MethodsThymic tissues were obtained from newborn children from nonatopic mothers, and thymocytes were cultured for 6 days with purified IgG from AD patients or with intravenous immunoglobulin (IVIG) or mock conditions as controls. Cells were gated as double positive T cells (TDP(-)CD4(+)CD8(+)), TCD4 cells (CD4(+)CD8(-)), or TCD8 cells (CD4(-)CD8(+)), and intracellular levels of IL-17A, IFN-, TNF-, IL-4, IL-10, and TGF- were evaluated by flow cytometry. ResultsCompared to mock and IVIG culture conditions, IgG of AD individuals induced in vitro intracellular production of IL-17 and IL-10 by intrathymic TDP, TCD4, and TCD8 cells of infants. TGF- was also detected at a higher frequency in response to AD IgG in TDP and TCD8 cells compared to mock and IVIG cultured conditions. An opposite effect was detected upon IFN- production in TCD4 cells, such that AD IgG reduced IFN- production compared to production under mock conditions but not under IVIG conditions. ConclusionIgG of AD patients can stimulate cytokine production in infant thymocytes and thus resembles the peripheral profile observed in adults. These findings suggest a novel mechanism that can contribute to AD pathogenesis.
Palavras-chave
Referências
  1. Batista DIS, 2015, J EUR ACAD DERMATOL, V29, P1091, DOI 10.1111/jdv.12753
  2. Belderbos ME, 2012, CLIN EXP ALLERGY, V42, P66, DOI 10.1111/j.1365-2222.2011.03857.x
  3. Bento-de-Souza Luciana, 2016, Results Immunol, V6, P15, DOI 10.1016/j.rinim.2016.04.001
  4. Czarnowicki T, 2015, J ALLERGY CLIN IMMUN, V136, P941, DOI 10.1016/j.jaci.2015.05.049
  5. Sgnotto FD, 2017, HUM VACC IMMUNOTHER, V13, P1563, DOI 10.1080/21645515.2017.1299299
  6. Lira AAD, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-47
  7. de Oliveira MG, 2017, ALLERGY ASTHMA CL IM, V13, DOI 10.1186/s13223-017-0195-8
  8. de Saint-Vis B, 1998, J IMMUNOL, V160, P1666
  9. Esaki H, 2016, J ALLERGY CLIN IMMUN, V138, P1639, DOI 10.1016/j.jaci.2016.07.013
  10. Fusaro AE, 2002, INT ARCH ALLERGY IMM, V127, P208, DOI 10.1159/000053865
  11. Fusaro AE, 2007, IMMUNOLOGY, V122, P107, DOI 10.1111/j.1365-2567.2007.02618.x
  12. Fusaro AE, 2009, IMMUNOLOGY, V128, pe541, DOI 10.1111/j.1365-2567.2008.03028.x
  13. Futata EA, 2006, IMMUNOBIOLOGY, V211, P157, DOI 10.1016/j.imbio.2005.08.006
  14. Gurkan A, 2016, ACTA DERMATOVENER CR, V24, P268
  15. Hamel Y, 2016, J AUTOIMMUN, V73, P54, DOI 10.1016/j.jaut.2016.06.003
  16. Han SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488
  17. Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x
  18. Huang F, 2008, J ALLERGY CLIN IMMUN, V121, P1415, DOI 10.1016/j.jaci.2008.04.016
  19. JARRETT EEE, 1983, IMMUNOLOGY, V48, P49
  20. Jenmalm MC, 2000, CLIN EXP ALLERGY, V30, P34, DOI 10.1046/j.1365-2222.2000.00771.x
  21. Kaesler S, 2014, J ALLERGY CLIN IMMUN, V134, P92, DOI 10.1016/j.jaci.2014.02.017
  22. Kim HS, 2015, STEM CELLS, V33, P1254, DOI 10.1002/stem.1913
  23. Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111
  24. Lemieux W, 2005, MOL IMMUNOL, V42, P839, DOI 10.1016/j.molimm.2004.07.046
  25. Lesiak A, 2014, ARCH MED SCI, V10, P1239, DOI 10.5114/aoms.2014.47833
  26. Li J, 2015, PROCEEDINGS 3RD IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION ACPR 2015, P1, DOI 10.1109/ACPR.2015.7486454
  27. Ma L, 2014, J EUR ACAD DERMATOL, V28, P1079, DOI 10.1111/jdv.12288
  28. Martel BC, 2016, INFLAMM RES, V65, P265, DOI 10.1007/s00011-015-0912-z
  29. Muniz BP, 2014, IMMUNOBIOLOGY, V219, P377, DOI 10.1016/j.imbio.2014.01.002
  30. Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015
  31. Oliveira CR, 2005, J CLIN IMMUNOL, V25, P153, DOI 10.1007/s10875-005-2821-3
  32. Rigato PO, 2009, IMMUNOTHERAPY, V1, P141, DOI [10.2217/1750743X.1.1.141, 10.2217/1750-743X.1.1.141]
  33. Sato M. N., 2002, Clinical and Experimental Allergy, V32, P1667, DOI 10.1046/j.1365-2222.2002.01429.x
  34. Sato MN, 2001, J INTERF CYTOK RES, V21, P827, DOI 10.1089/107999001753238079
  35. Seltmann J, 2013, EXP DERMATOL, V22, P102, DOI 10.1111/exd.12076
  36. Seneviratne SL, 2006, CLIN EXP DERMATOL, V31, P689, DOI 10.1111/j.1365-2230.2006.02172.x
  37. Simon D, 2007, BRIT J DERMATOL, V157, P583, DOI 10.1111/j.1365-2133.2007.08050.x
  38. Stach SCL, 2014, AM J REPROD IMMUNOL, V72, P555, DOI 10.1111/aji.12305
  39. Tan Q, 2017, J CUTAN MED SURG, V21, P308, DOI 10.1177/1203475417697651
  40. Vance GHS, 2004, CLIN EXP ALLERGY, V34, P1855, DOI 10.1111/j.1365-2222.2004.02111.x
  41. VANDERPOLL T, 1994, J EXP MED, V180, P1985, DOI 10.1084/jem.180.5.1985
  42. Victor JR, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-11
  43. Victor JR, 2017, HUM VACC IMMUNOTHER, V13, P507, DOI 10.1080/21645515.2016.1244592
  44. Victor JR, 2014, J IMMUNOL RES, DOI 10.1155/2014/780386
  45. Victor JR, 2003, J ALLERGY CLIN IMMUN, V111, P269, DOI 10.1067/mai.2003.39
  46. Volz T, 2014, J INVEST DERMATOL, V134, P96, DOI 10.1038/jid.2013.291
  47. WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853
  48. Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X
  49. Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308
  50. Wu KH, 2006, PEDIATR ALLERGY IMMU, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x